Raymond AK, Jaffe N. Osteosarcoma multidisciplinary approach to the management from the pathologist’s perspective. Cancer Treat Res. 2009;152:63–84.
Article
Google Scholar
Messerschmitt PJ, Garcia RM, Abdulkarim FW, Greenfield EM, Getty PJ. Osteosarcoma. J Am Acad Orthop Surg. 2009;17:515.
Article
Google Scholar
Sampo M, Koivikko M, Taskinen M, Kallio P, Kivioja A, Tarkkanen M, Böhling T. Incidence, epidemiology and treatment results of osteosarcoma in Finland—a nationwide population-based study. Acta Oncol. 2011;50:1206–14.
Article
Google Scholar
Arndt CAS, Rose PS, Folpe AL, Laack NN. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med. 2012;87:475–87.
Google Scholar
Jo VY, Fletcher CDM. WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology. 2014;46:95–104.
Article
Google Scholar
Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment—where do we stand? A state of the art review. Cancer Treat Rev. 2014;40:523–32.
Article
Google Scholar
Ferrari S, Mercuri M, Bacci G. Comment on “Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.” J Clin Oncol. 2004;17:131–7.
Google Scholar
Isakoff MS, Bielack SS, Meltzer P, Gorlick R. Osteosarcoma: current treatment and a collaborative pathway to success. J Clin Oncol. 2015. https://doi.org/10.1200/JCO.2014.59.4895.
Article
Google Scholar
Meyers PA, Gorlick R. Osteosarcoma. Pediatr Clin N Am. 1997;44:973–89.
Article
Google Scholar
Kaste SC, Charles BP, Alvida MC, Dana JJ-W, Bhaskar NR. Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis: imaging features. Cancer. 1999;86:1602–8.
Article
Google Scholar
Posthumadeboer J, Witlox MA, Kaspers GJL, van Royen BJ. Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature. Clin Exp Metastasis. 2011;28:493–503.
Article
Google Scholar
Yonemoto T, Tatezaki S-I, Ishii T, Satoh T, Kimura H, Iwai N. Prognosis of osteosarcoma with pulmonary metastases at initial presentation is not dismal. Clin Orthop Relat Res. 1998;349:194–9.
Article
Google Scholar
Mirabello L, Troisi RJ, Savage SA. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer. 2009;125:229–34.
Article
Google Scholar
Mirabello L, Rebecca JT, Sharon AS. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer. 2009;115:1531–43.
Article
Google Scholar
Entz-Werle N, Schneider A, Kalifa C, Voegeli A-C, Tabone M-D, Marec-Berard P, Marcellin L, Pacquement H, Terrier P, Boutard P. Genetic alterations in primary osteosarcoma from 54 children and adolescents by targeted allelotyping. Br J Cancer. 2003;88:1925–31.
Article
Google Scholar
Claudio PP, Maraldi NM, Howard JC, Neri AL, Fu AKY, Giordano FA, Cinti C, Tosi G, Leoncini L. Genetic alterations disrupting the nuclear localization of the retinoblastoma-related gene RB2/p130 in human tumor cell lines and primary tumors. Cancer Res. 2000;60:383–9.
Google Scholar
Ferrari S, Palmerini E. Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr Opin Oncol. 2007;19:341–6.
Article
Google Scholar
Anderson ME. Update on survival in osteosarcoma. Orthop Clin N Am. 2016;47:283–92.
Article
Google Scholar
O’Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445:106–10.
Article
Google Scholar
Ritter J, Bielack SS. Osteosarcoma. Ann Oncol. 2010;21:vii320–5.
Article
Google Scholar
Klein MJ, Siegal GP. Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol. 2006;125:555–81.
Article
Google Scholar
Suresh S, Saifuddin A. Radiological appearances of appendicular osteosarcoma: a comprehensive pictorial review. Clin Radiol. 2007;62:0–323.
Article
Google Scholar
Pahade J, Sekhar A, Shetty SK. Imaging of malignant skeletal tumors. Cancer Treat Res. 2008;143:367–422.
Article
Google Scholar
Murphey MD, Robbin MR, McRae GA, Flemming DJ, Temple HT, Kransdorf MJ. The many faces of osteosarcoma. Radiographics. 1997;17:1205–31.
Article
Google Scholar
Pringle JAS. Osteosarcoma: the experiences of a specialist unit. Curr Diagn Pathol. 1996;3:127–36.
Article
Google Scholar
Min SK, Lee SY, Wan HC, Song WS, Jeon DG. Initial tumor size predicts histologic response and survival in localized osteosarcoma patients. J Surg Oncol. 2008;97:456–61.
Article
Google Scholar
Enneking WF, Spanier SS, Goodman MA. Current concepts review. The surgical staging of musculoskeletal sarcoma. J Bone Joint Surg. 1980;62:1027–30.
Article
Google Scholar
Edge SB, Carolyn CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–4.
Article
Google Scholar
Moore DD, Luu HH. Osteosarcoma. Cancer Treat Res. 2014;162:65.
Article
Google Scholar
Pesternikov VM, Bukhtoiarova ZM. Experimental x-ray diagnosis of osteosarcoma. Vopr Onkol. 1975;21:58–62.
Google Scholar
Pilcher LS. Surgery: its principles and practice. 1906.
Lietman SA. Soft-tissue sarcomas: overview of management, with a focus on surgical treatment considerations. Cleve Clin J Med. 2010;77(Suppl 1):S13.
Article
Google Scholar
X-ray diagnosis of extraskeletal osteosarcoma (a report 4 cases). Mod Med Imagel. 2010.
Heller M, Jend HH, Bücheler E, Hueck E, Viehweger G. The role of CT in diagnosis and follow-up of osteosarcoma. J Cancer Res Clin Oncol. 1983;106(Suppl):43–8.
Article
Google Scholar
Majó J, Cubedo R, Pardo N. Treatment of osteosarcoma. A review. Revista Española De Cirugía Ortopédica Y Traumatología. 2010;54:329–36.
Article
Google Scholar
Kayton ML, Andrew GH, Jennifer C, Sara JA, Nancy SR, Leonard HW, Paul M, Michael PL. Computed tomographic scan of the chest underestimates the number of metastatic lesions in osteosarcoma. J Pediatr Surg. 2006;41:1–206.
Article
Google Scholar
Hogendoorn PCW, Athanasou N, Bielack S, Alava ED, Dei Tos AP, Ferrari S, Gelderblom H, Grimer R, Hall KS, Hassan B. Bone sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21:21–6.
Article
Google Scholar
Kumar R, Kumar M, Malhotra K, Patel S. Primary osteosarcoma in the elderly revisited: current concepts in diagnosis and treatment. Curr Oncol Rep. 2018;20:13.
Article
Google Scholar
Bajpai J, Gamnagatti S, Sreenivas V, Phulia R, Sharma M, Khan SA, Rastogi S, Safaya R, Malhotra A, Bakhshi S. Role of MRI in osteosarcoma for chemotherapy response evaluation and prediction: correlation with histological necrosis. J Clin Oncol. 2009;27:10540.
Article
Google Scholar
Geller DS, Gorlick R. Osteosarcoma: a review of diagnosis, management, and treatment strategies. Clin Adv Hematol Oncol. 2010;8:705–18.
Google Scholar
Dönmez FY, Tüzün U, Başaran C, Tunaci M, Acunaş G. MRI findings in parosteal osteosarcoma: correlation with histopathology. Diagn Intervent Radiol. 2008;14:142–52.
Google Scholar
Kager L. Skip metastases in osteosarcoma: experience of the cooperative osteosarcoma study group. J Clin Oncol. 2006;24:1535–41.
Article
Google Scholar
Sajadi KR, Heck RK, Neel MD, Rao BN, Daw N, Rodriguez-Galindo C, Hoffer FA, Stacy GS, Peabody TD, Simon MA. The incidence and prognosis of osteosarcoma skip metastases. Clin Orthop Relat Res. 2004;426:92–6.
Article
Google Scholar
Xie X. Diagnosis and progress in biological treatment of osteosarcoma. HJBM. 2019;09:114–20. https://doi.org/10.12677/HJBM.2019.93017.
Article
Google Scholar
Cao Q, Lu M, Huebner T, Dilsizian V, Chen W. 18F-FDG PET/CT in a rare malignant extraskeletal osteosarcoma. Clin Nucl Med. 2013;38:e367–9.
Article
Google Scholar
Farghaly R, Zaki I, Gouda I, Abdelfatah M, El Ghoneimy A, El Sherbiny M, Soliman R, Zamzam M. Value of dynamic magnetic resonance imaging in preoperative evaluation of pediatric osteosarcoma. Egypt J Radiol Nucl Med. 2017;48:461–5.
Article
Google Scholar
del Rosal JAC, Cañadell J. Biopsy technique in the treatment of osteosarcoma. Int Orthop. 1994;18:375–8.
Google Scholar
Honoki K. Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines. Int J Oncol. 2009;34:1381–6.
Google Scholar
Accurate diagnosis of musculoskeletal lesions by core needle biopsy. J Surg Oncol. 2010;94:21–7.
Panzica M, Lüke U, Mommsen P, Krettek C. Biopsy and approach routes for bone tumors. Where and how much is sufficient? Der Unfallchirurg. 2014;117:501–9.
Article
Google Scholar
Yuan J, Zhang H, Jiang Z, Zhou J, Zhang Z. Accuracy of different preoperative biopsy techniques in diagnosis of osteosarcomas and their value in prognostic evaluation. Zhonghua Bing LI Xue Za Zhi Chin J Pathol. 2015;44:315–9.
Google Scholar
Betz M, Dumont CE, Fuchs B, Exner UG. Physeal distraction for joint preservation in malignant metaphyseal bone tumors in children. Clin Orthop Relat Res. 2012;470:1749–54.
Article
Google Scholar
Marulanda GA, Henderson ER, Johnson DA, Letson GD, Cheong D. Orthopedic surgery options for the treatment of primary osteosarcoma. Cancer Control J Moffitt Cancer Center. 2008;15:13–20.
Article
Google Scholar
Sweetnam R. Amputation in osteosarcoma. Bone Joint J. 1975;57:268–9.
Google Scholar
Malawer MM, Mchale KA. Limb-sparing surgery for high-grade malignant tumors of the proximal tibia. Surgical technique and a method of extensor mechanism reconstruction. Clin Orthop Relat Res. 1989;239:231–48.
Article
Google Scholar
Xu M, Wang Z, Yu X-C, Lin J-H, Hu Y-C. Guideline for limb-salvage treatment of osteosarcoma. Orthop Surg. 2020;12:1021–9. https://doi.org/10.1111/os.12702.
Article
Google Scholar
Hasley I, Gao Y, Blevins A, Miller B. The significance of a “close” margin in extremity sarcoma: a systematic review. Iowa Orthop J. 2018;38:123–30.
Google Scholar
Levin AS, Arkader A, Morris CD. Reconstruction following tumor resections in skeletally immature patients. JAAOS J Am Acad Orthop Surg. 2017;25:204–13. https://doi.org/10.5435/JAAOS-D-15-00619.
Article
Google Scholar
Simpson E, Brown HL. Understanding osteosarcomas. JAAPA. 2018;31:15–9. https://doi.org/10.1097/01.JAA.0000541477.24116.8d.
Article
Google Scholar
Kim HJ, Chalmers PN, Morris CD. Pediatric osteogenic sarcoma. Curr Opin Pediatr. 2010;22:61–6.
Article
Google Scholar
Zhao J, Xu M, Zheng K, Yu X. Limb salvage surgery with joint preservation for malignant humeral bone tumors: operative procedures and clinical application. BMC Surg. 2019;19:57. https://doi.org/10.1186/s12893-019-0519-3.
Article
Google Scholar
Yang Y, Han L, He Z, Li X, Yang S, Yang J, Zhang Y, Li D, Yang Y, Yang Z. Advances in limb salvage treatment of osteosarcoma. J Bone Oncol. 2018;10:36–40. https://doi.org/10.1016/j.jbo.2017.11.005.
Article
Google Scholar
Misaghi A, Goldin A, Awad M, Kulidjian AA. Osteosarcoma: a comprehensive review. SICOT-J. 2018;4:12.
Article
Google Scholar
Kleinerman ES, Gorlick R. Current advances in osteosarcoma. Cham: Springer International Publishing; 2020. 978-3-030-43031-3.
Book
Google Scholar
Harrison DJ, Geller DS, Gill JD, Lewis VO, Gorlick R. Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer Ther. 2018;18:39–50. https://doi.org/10.1080/14737140.2018.1413939.
Article
Google Scholar
Ferrari S, Serra M. An update on chemotherapy for osteosarcoma. Expert Opin Pharmacother. 2015;16:1–10.
Article
Google Scholar
Winkler K, Beron G, Delling G, Heise U, Kabisch H, Purfürst C, Berger J, Ritter J, Jürgens H, Gerein V. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol. 1988;6:329–37.
Article
Google Scholar
Link MP, Goorin AM, Horowitz M, Meyer WH, Belasco J, Baker A, Ayala A, Shuster J. Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Clin Orthop Relat Res. 1991;270:8–14.
Article
Google Scholar
Li X, Zhang Y, Wan S, Li H, Li D, Xia J, Yuan Z, Ren M, Yu S, Li S. A comparative study between limb-salvage and amputation for treating osteosarcoma. J Bone Oncol. 2016;5:15–21.
Article
Google Scholar
Eaton BR, Schwarz R, Vatner R, Yeh B, Claude L, Indelicato DJ, Laack N. Osteosarcoma. Pediatr Blood Cancer. 2020. https://doi.org/10.1002/pbc.28352.
Article
Google Scholar
Winkler K, Bielack SS, Delling G, Jürgens H, Salzer-Kuntschik M. Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS). Cancer Treat Res. 1993;62:269–77.
Article
Google Scholar
Turner H, Séguin B, Worley DR, Ehrhart NP, Lafferty MH, Withrow SJ, Selmic LE. Prognosis for dogs with stage III osteosarcoma following treatment with amputation and chemotherapy with and without metastasectomy. J Am Vet Med Assoc. 2017;251:1293–305.
Article
Google Scholar
Schwartz CL, Wexler LH, Krailo MD, Teot LA, Devidas M, Steinherz LJ, Goorin AM, Gebhardt MC, Healey JH, Sato JK. Intensified chemotherapy with dexrazoxane cardioprotection in newly diagnosed nonmetastatic osteosarcoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2016;63:54–61.
Article
Google Scholar
Whelan J, Seddon B, Perisoglou M. Management of osteosarcoma. Curr Treat Options Oncol. 2006;7:444–55.
Article
Google Scholar
Russo C, Lavorgna M, Česen M, Kosjek T, Isidori M. Evaluation of acute and chronic ecotoxicity of cyclophosphamide, ifosfamide, their metabolites/transformation products and UV treated samples. Environ Pollut. 2017;233:356–63.
Article
Google Scholar
Aznab M, Hematti M. Evaluation of clinical process in osteosarcoma patients treated with chemotherapy including cisplatin, adriamycin, ifosfamide, and etoposide and determination of the treatment sequels in a long-term 11-year follow-up. J Cancer Res Ther. 2017;13:291.
Article
Google Scholar
Kumari P, Ghosh B, Biswas S. Nanocarriers for cancer-targeted drug delivery. J Drug Target. 2016;24:179–91. https://doi.org/10.3109/1061186X.2015.1051049.
Article
Google Scholar
Wang S-Y, Hu H-Z, Qing X-C, Zhang Z-C, Shao Z-W. Recent advances of drug delivery nanocarriers in osteosarcoma treatment. J Cancer. 2020;11:69–82. https://doi.org/10.7150/jca.36588.
Article
Google Scholar
Delaney TF, Park L, Goldberg SI, Hug EB, Liebsch NJ, Munzenrider JE, Suit HD. Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol. 2005;61:492–8.
Article
Google Scholar
Hall MD, Laack N, Indelicato DJ. Ewing sarcoma and osteosarcoma. Cham: Springer; 2019.
Book
Google Scholar
Mahajan A, Woo SY, Kornguth DG, Hughes D, Anderson P. Multimodality treatment of osteosarcoma: radiation in a high-risk cohort. Pediatr Blood Cancer. 2008;50:976–82.
Article
Google Scholar
Machak GN, Tkachev SI, Solovyev YN, Sinyukov PA, Ivanov SM, Kochergina NV, Ryjkov AD, Tepliakov VV, Bokhian BY, Glebovskaya VV. Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities. Mayo Clin Proc. 2003;78:147–55. https://doi.org/10.4065/78.2.147.
Article
Google Scholar
Ciernik IF, Andrzej N, David CH, Wendy K, Yen-Lin C, Torunn IY, David HE, Edwin C, Kevin AR, Norbert L. Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma. Cancer. 2011;117:4522–30.
Article
Google Scholar
Mamo TK. Sensitizing osteosarcoma to radiation therapy. 2017.
Tao S, Yu ZX, Yang L, Qi Z, Ke S. Ginseng polysaccharide serves as a potential radiosensitizer through inducing apoptosis and autophagy in the treatment of osteosarcoma. Kaohsiung J Med Sci. 2017;33:535–42.
Article
Google Scholar
Kumar N, Gupta B. Global incidence of primary malignant bone tumors. Curr Orthop Pract. 2016;27:530–4.
Article
Google Scholar
Brown LC, Lester RA, Grams MP, Haddock MG, Olivier KR, Arndt CAS, Rose PS, Laack NN. Stereotactic body radiotherapy for metastatic and recurrent Ewing sarcoma and osteosarcoma. Sarcoma. 2014;2014:418270.
Article
Google Scholar
Frisch S, Timmermann B. The evolving role of proton beam therapy for sarcomas. Clin Oncol. 2017;29:500–6.
Article
Google Scholar
Osama M, Brock S, Janapriya S, Arnold P, Asal R, Michael S, Anthony D, Kim DW. Carbon ion radiotherapy: a review of clinical experiences and preclinical research, with an emphasis on DNA damage/repair. Cancers. 2017;9:66.
Article
Google Scholar
Eilber FR, Townsend C, Morton DL. Osteosarcoma: results of treatment employing adjuvant immunotherapy. Clin Orthop Relat Res. 1975;111:94.
Article
Google Scholar
Mori K, Rédini F, Gouin F, Cherrier B, Heymann D. Osteosarcoma: current status of immunotherapy and future trends (Review). Oncol Rep. 2006;15:693–700.
Google Scholar
Loeb DM. Is there a role for immunotherapy in osteosarcoma? Cancer Treat Res. 2009;152:447.
Article
Google Scholar
Smyth MJ, Cretney E, Kershaw MH, Hayakawa Y. Cytokines in cancer immunity and immunotherapy. Immunol Rev. 2004;202:275–93.
Article
Google Scholar
Mori K, Ando K, Matsusue Y, Heymann D. Chapter 34—Current status of immunotherapy for osteosarcoma and its future trends. In: Heymann D, editor. Bone cancer. San Diego: Academic Press; 2010. p. 417–25. 978-0-12-374895-9.
Chapter
Google Scholar
Miwa S, Shirai T, Yamamoto N, Hayashi K, Takeuchi A, Igarashi K, Tsuchiya H. Current and emerging targets in immunotherapy for osteosarcoma. J Oncol. 2019;2019:7035045. https://doi.org/10.1155/2019/7035045.
Article
Google Scholar
Meazza C, Cefalo G, Massimino M, Daolio P, Pastorino U, Scanagatta P, Morosi C, Podda M, Ferrari A, Terenziani M. Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2. Med Oncol. 2017;34:191.
Article
Google Scholar
Steinman RM. Immunotherapy: bewitched, bothered, and bewildered no more. Science. 2004;305:197–200.
Article
Google Scholar
Wedekind MF, Wagner LM, Cripe TP. Immunotherapy for osteosarcoma: where do we go from here? Pediatr Blood Cancer. 2018;65:e27227. https://doi.org/10.1002/pbc.27227.
Article
Google Scholar
Weekly I. Gene therapy for osteosarcoma 1996;1063:11.
Broadhead ML, Clark JCM, Choong PFM, Dass CR. Making gene therapy for osteosarcoma a reality. Expert Rev Anticancer Ther. 2010;10:477–80.
Article
Google Scholar
Dass CR, Choong PFM. Gene therapy for osteosarcoma: steps towards clinical studies. J Pharm Pharmacol. 2008;60:405–13.
Article
Google Scholar
Marshall JC, Bakalian S, Martins CMDO. Metastasis suppressor genes. New York: Springer; 2013.
Book
Google Scholar
Ru JY, Cong Y, Kang WB, Yu L, Zhao JN. Polymorphisms in TP53 are associated with risk and survival of osteosarcoma in a Chinese population. Int J Clin Exp Pathol. 2015;8:3198–203.
Google Scholar
Wu J, Guo A, Li Q, Wang D. Meta-analysis of clinical significance of p53 protein expression in patients with osteosarcoma. Future Oncol. 2017;13:1883–91.
Article
Google Scholar
Ye S, Shen J, Choy E, Yang C, Mankin H, Hornicek F, Duan Z. p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines. Cancer Chemother Pharmacol. 2016;77:349–56.
Article
Google Scholar
Zhang HD, Lu Z, Feng Y, Liu XL, Hou HM. Experimental research in vitro of TK/GCV system for osteosarcoma MG-63 cell damage. Zhongguo Gu Shang. 2014;27:240–3.
Google Scholar
Leinonen HM, Ruotsalainen A-K, Maatta A-M, Laitinen HM, Kuosmanen SM, Kansanen E, Pikkarainen JT, Lappalainen JP, Samaranayake H, Lesch HP. Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatment. Cancer Res. 2012;72:6227–35.
Article
Google Scholar
Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res. 1986;46:5276–81.
Google Scholar
Oryan A, Alidadi S, Moshiri A. Osteosarcoma: current concepts, challenges and future directions. Curr Orthop Pract. 2015;26:181–98.
Article
Google Scholar